Back to blog

Broadcom Has Growth Potential After Stock Price Correction! Why?

Earnings season continues, with another company surpassing analyst estimates: tech giant Broadcom Inc. A key factor in its growth was revenue from the artificial intelligence (AI) segment, along with strong results from its software division. Given the nearly 30% drop in its stock price, these results are even more significant as they have the potential to restore the growth trend, giving investors the opportunity to buy at a more favourable valuation.*

Broadcom Has Growth Potential After Stock Price Correction! Why?

Beating Wall Street Estimates

According to analysts from London Stock Exchange Group (LSEG), Broadcom was expected to achieve earnings per share (EPS) of $1.49. However, the actual adjusted EPS was $1.60. Following this, the company also exceeded revenue projections.* Revenue was expected to be $14.61 billion, but the company crossed this line and reported $14.92 billion.

Strong performance led to positive outlooks for the second quarter. Broadcom expects revenue of $14.9 billion, which is higher than analysts' estimate of $14.76 billion. [1]

Compared to the same period last year, Broadcom experienced a 25% year-over-year increase in revenue, reaching $11.96 billion in Q1 2024. Even more impressive was the growth in net income, which rose to $5.5 billion ($1.14 per share), compared to $1.33 billion ($0.28 per share) the year before.*

AI Segment on the Rise

A closer look at the company's segment performance shows that one of the main growth drivers was artificial intelligence. Revenue from AI solutions reached $4.1 billion, reflecting a 77% year-over-year increase. This segment falls under the semiconductor division, which overall saw $8.21 billion in revenue, marking an 11% year-over-year growth.

Broadcom also expects AI revenue to rise to $4.4 billion in the second quarter. The company is already collaborating with three major cloud providers and two hyperscaler companies to develop its own AI chips. CEO Hock Tan also emphasized to CNBC that Broadcom is focusing only on large partners who can deploy its products on a massive scale, suggesting stability in its revenue stream.

Rapidly Growing Software Division

In addition to the AI segment, Broadcom's software division also showed strong growth, reporting revenue of $6.7 billion, a 47% year-over-year increase. This growth is largely the result of the VMware acquisition completed at the end of 2023, helping the company diversify its revenue and significantly reduce dependence on its semiconductor business.

Market Reaction

Broadcom's stock saw nearly a 20% increase in after-hours trading following the release of these results on March 6, 2025. This suggests that the price positively responded not only to the strong earnings but also to the optimistic outlook for the next quarter. As of March 10, 2025, the stock price had dropped to $186.*

broadcom

Source: Tradingeconomics.com*

It's important to note that before this increase, Broadcom's stock had been under pressure. Since the beginning of 2025, the stock had fallen by approximately 30%, driven by concerns about potential regulatory changes related to President Donald Trump's trade policy.* However, strong quarterly results showed that Broadcom has the potential to reverse this correction, which investors can take advantage of.

Conclusion

Broadcom's Q1 2025 results demonstrated that the company has stable foundations for continued growth. The strong performance of the AI segment and the expanding software division ensure diversified revenue streams. While the company's stock faced pressure in recent months, the latest numbers show that Broadcom continues to maintain its position as a leader in semiconductor and software solutions. [2]

 

* Historical data is not a guarantee of future performance.

[1], [2] Forward-looking statements represent assumptions and current expectations that may not be accurate or are based on current economic conditions that may change. These statements are not guarantees of future performance. Forward-looking statements by their nature involve risk and uncertainty because they relate to future events and circumstances that cannot be predicted and actual developments and results may differ materially from those expressed or implied by any forward-looking statements.

Caution! This marketing material is not and should not be construed as investment advice. Historical data is not a guarantee of future performance. Investing in foreign currencies may affect returns due to fluctuations. All securities transactions may result in both profits and losses. Forward-looking statements represent assumptions and current expectations that may not be accurate or are based on current economic conditions that may change. These statements are not guarantees of future performance. InvestingFox is a trademark of CAPITAL MARKETS, o.c.p., a.s. regulated by the National Bank of Slovakia.

 

Sources:

https://investors.broadcom.com/news-releases/news-release-details/broadcom-inc-announces-first-quarter-fiscal-year-2025-financial

https://www.cnbc.com/2025/03/06/broadcom-avgo-earnings-report-q1-2025-.html

https://investors.broadcom.com/static-files/602c2fd3-89a0-436f-b638-4890f20feda7

 

 

Read more

Strong Results, Weak Market Reaction – What’s Happening with Nvidia?

Strong Results, Weak Market Reaction – What’s Happening with Nvidia?

One of the most popular companies on Wall Street, Nvidia, released its earnings on Wednesday, February 26, 2025, confirming impressive growth in the AI chip segment. Despite this, its stock faced pressure due to expectations of a decline in gross margin, which created uncertainty among investors. However, the positive news is that Nvidia has secured enough manufacturing capacity for this year with its main supplier, TSMC. Yet, it faces the risk of new tariffs imposed by the US government.

Eli Lilly Lowers the Price of Its Weight Loss Drug: More Affordable Treatment or Strategic Business Move?

Eli Lilly Lowers the Price of Its Weight Loss Drug: More Affordable Treatment or Strategic Business Move?

Pharmaceutical giant Eli Lilly has made a significant shift in its pricing strategy for the popular weight-loss drug Zepbound. The company announced that selected doses would be available at a lower price to help patients without adequate health insurance while strengthening its market position. This move comes at a time when regulatory authorities have declared the end of the drug shortage, and Eli Lilly faces growing competition. Additionally, the company is investing heavily in developing an oral alternative, which could significantly reshape the market. 

Mercedes-Benz: New Strategies on the Road to Reviving the European Market

Mercedes-Benz: New Strategies on the Road to Reviving the European Market

Recent financial results from Mercedes-Benz reveal that the company faced a harsh wake-up call last year, as it struggled with the slowing shift to electric vehicles and weakening demand in China, once an inexhaustible source of profits for German automakers. Its challenges reflect the tough period during which European vehicle manufacturers are grappling with sharp declines in sales, especially in the electric vehicle sector. However, early sales data for this year suggests improvement, which could be the first sign of market recovery.

CVS Health closed 2024 with strong results and ambitious growth plans

CVS Health closed 2024 with strong results and ambitious growth plans

CVS Health, one of the largest healthcare companies in the U.S., surprised investors with positive results for the fourth quarter of 2024. Despite challenges, it managed to exceed expectations and demonstrated stable growth in key segments. The company also presented ambitious plans for 2025, which include cost reduction and strategic improvements in Medicare Advantage insurance.